10 Triumphant Drug Launches Of The Decade
Executive Summary
The view from 2020: Scrip looks back at the most successful commercial launches of the decade.
You may also be interested in...
BioNTech Deal Shows Pfizer Is Reinvesting COVID-19 Windfall In mRNA
The companies’ third vaccine-development deal shows how COVID cash has also led mRNA-focused companies to beef up their organic pipelines amid talk of a merger wave.
Credit Where It Is Due: Pfizer’s COVID-19 Vaccine Smashes Launch Records As Expected
Pfizer said it expects to generate $26bn in annual revenues from the COVID-19 vaccine BNT162b2 and is leveraging the platform to build out a durable business.
Pfizer’s 20-Valent Vaccine And Prevnar Successor Succeeds In Phase III
The company still plans to file 20vPnC for US FDA approval by the end of 2020 after the pneumococcal vaccine was non-inferior to Prevnar and to Pneumovax on six additional serotypes in older patients.